NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3)
Funds the implementation of a clinical trial in arthritis, musculoskeletal or skin disease as a phased cooperative agreement with the institute.
This is the National Institute of Arthritis and Musculoskeletal and Skin Diseases' route for actually running a trial, once there is one to run.
The mechanism is a phased cooperative agreement. Phased means the second stage depends on the first meeting its milestones. Cooperative means institute staff take an active part in the project rather than watching it.
The scope is the institute's own mi…
Phased cooperative agreements implementing clinical trials within the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, covering arthritis and rheumatic diseases, musculoskeletal conditions and skin diseases. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up